Recently, the DETECT Trial reported that 111In-PSMA-I&T facilitated the resection of PSMA-avid lesions, of which 97% were confirmed as LNMs in 20 newly diagnosed PCa patients 36. Here, FOLH1 is linked to posterior cortical atrophy.